Navigation Links
Star Scientific Breaks New Ground, Plans FDA Filing for Approval of First 'Modified Risk' Tobacco Product; Nominates Curtis Wright, MD, MPH for FDA Advisory Committee
Date:9/22/2009

found in several nicotine replacement therapy products (NRT) as reported by a University of Minnesota research team in December, 2007.

Late last week Star Scientific submitted comments to the FDA in response to the agency's request for input on the regulatory framework established by the Family Smoking Prevention and Tobacco Control Act, which was signed into law by President Obama in June, 2009. The company's comments, which can be viewed at http://www.regulations.gov/search/Regs/home.html#documentDetail?R=0900006480a2524f, focus on the need for tobacco product labeling that lists the levels of the most lethal carcinogens in the products in a way that is clear to adult tobacco users. Paul L. Perito, Star's chairman and president commented that "Adult tobacco users need to have access to information about the spectrum of harm associated with tobacco use in order to be able make informed choices about the products they purchase." Mr. Perito added that he hopes clear and accurate labeling will be one of the cornerstones of tobacco regulation policy.

The company also formally nominated Dr. Wright for a position on the Scientific Advisory Committee that has been established by the FDA under the new legislation. In a letter submitted to the agency on September 21, the company pointed out that "Dr. Wright has an enormous breadth of experience in the area of addictive substances, and eight years of his career were spent at the Food & Drug Administration. . .Dr. Wright can contribute not only as a scientist, but also as an executive with significant industry experience. "

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Star Scientific, Inc. and its consolidated subsidiaries (collectively, the "Company") has tri
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Boston Scientific PROMUS(R) and First-Generation TAXUS(R) Express(R) Stents Continue Excellent Performance in SPIRIT III Trial
2. Dean MacCarter, Ph.D. Addressed Differentiation of Responder vs Non-Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting
3. Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office
4. American Scientific Resources, Inc. Welcomes Jason Roth
5. GENova appoints Dr. Wang Chong to Scientific Advisory Board
6. American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device
7. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
8. GENova appoints Dr. Philip Gould to Scientific Advisory Board
9. Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference
10. Patriot Scientific Corporation Announces Alcon Inc.s Purchase of a Moore Microprocessor Patent(TM) Portfolio License
11. Sambazon Announces Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 Come see, swim in, and soak ... that competitive edge and to continue to be the most decorated ... Tubs will be on display at The Toledo Hot Tub, Swim ... Rec Center. , Tim Baele, Regional Sales Manager for Master Spas, ... the best place to see hundreds of great products and build ...
(Date:7/24/2014)... Hayes, Inc. ( http://www.hayesinc.com ), a leader ... evidence, is pleased to announce that Dee Donatelli, Senior ... at the AHRMM14 Conference in Orlando, FL, ... value analysis who also serves as the current President ... will facilitate and participate in two preconference sessions on ...
(Date:7/24/2014)... 24, 2014 Angeldress.co.uk, a renowned wedding ... worldwide ladies to obtain their dream garments at affordable ... best special occasion outfits for clients from all over ... the latest designs and the information on how to ... , Recently, the company has unveiled its new collection ...
(Date:7/24/2014)... 2014 In response to a ... patients may benefit from parathyroidectomy, Dr. Babak Larian ... Beverly Hills today commented on hyperparathyroidism, a commonly ... misdiagnosed because its symptoms are vague and similar ... who have been diagnosed with fibromyalgia may actually ...
(Date:7/24/2014)... Osteoporosis is one of the most devious diseases ... as recent research goes, there are now many factors ... than post-menopause and lack of calcium intake. Older people now ... some point in their lives. , However, that does not ... Alsop was a former sufferer who had managed to rebuild ...
Breaking Medicine News(10 mins):Health News:See the New Michael Phelps Swim Spas and Hot Tubs at The Toledo Hot Tub, Swim Spa, Pool & Patio Show at the Lucas County Rec Center this Weekend 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 3Health News:Angeldress.co.uk, A Renowned Wedding Dress Manufacturer And Retailer, Vows To Offer The Best Bridesmaid Dresses For Ladies 2Health News:Is Hyperparathyroidism Misdiagnosed as Fibromyalgia? 2Health News:Is Hyperparathyroidism Misdiagnosed as Fibromyalgia? 3Health News:The Truth About Osteoporosis Review | The Ultimate Secret to Treating Osteoporosis in a Natural and Safe Manner – Vinamy.com 2Health News:The Truth About Osteoporosis Review | The Ultimate Secret to Treating Osteoporosis in a Natural and Safe Manner – Vinamy.com 3
... breakthrough that may aid treatment of learning impairments, strokes, ... that brain nerve stimulation accelerates learning in laboratory tests. ... the April 14 issue of Neuron , involves ... complete. Researchers monitoring brain activity in rats found that ...
... HealthDay Reporter , WEDNESDAY, April 13 (HealthDay News) ... supplements, such as multivitamins and calcium, and their use jumped ... government report. Between 1994 and 2006, the proportion of ... percent of adults to 53 percent, according to the U.S. ...
... Russians were faced with more than the demise of a ... country saw a 40 percent surge in deaths between 1990 ... much was clear. And for years, many economists and political ... driving those men to drink. They reasoned that privatization left ...
... , To ensure normal fetal development and prevent disease, it is ... time intervals. Researchers in Professor Kristian Helin,s group at BRIC, University ... activity of our genes. The results are just published in the ... ,The complete human genetic code was mapped in 2000. However, it ...
... optimistic; down the opposite. Right is honest and trustworthy. ... tell us. "We use mental metaphors to structure our ... of those metaphors is space." But we ... Rather, "people associate goodness with the side they can ...
... April 13 (HealthDay News) -- Bouts of near-intolerable itching are a ... a broken bone, but you need to be careful how you ... stick anything into your cast to scratch an itch. Never. I ... and chopsticks to forks and brushes," Dr. Paul Prinz, an orthopedic ...
Cached Medicine News:Health News:Making temporary changes to brain could speed up learning, study reports 2Health News:Making temporary changes to brain could speed up learning, study reports 3Health News:Use of Dietary Supplements Keeps Climbing: CDC 2Health News:Use of Dietary Supplements Keeps Climbing: CDC 3Health News:Stanford research casts sober light on Russia's mortality crisis 2Health News:Stanford research casts sober light on Russia's mortality crisis 3Health News:The TET1 enzyme steers us through fetal development and fights cancer 2Health News:Are your values right or left? The answer is more literal than you think 2
(Date:7/24/2014)... DIEGO , July 24, 2014 ... industry leader in bioactive lipid-targeted therapeutics, reported interim ... where ASONEP™ is being investigated as a treatment ... that have failed at least one therapy involving ... no more than one mTOR inhibitor (e.g., Afinitor®/everolimus), ...
(Date:7/24/2014)... , Revenues from continuing operations of ... diluted EPS from continuing operations of $1.08, up 1.9% versus  ... of $0.92, 7% below prior year , Cash from ... , Full year 2014 revenues now expected to be up ... , Full year 2014 adjusted diluted EPS range narrowed to  ...
(Date:7/24/2014)... HIGHLIGHTS:Q2 2014 Results (all percentage changes are against the same ... $701 million.  Sales grew organically by 2%, and changes in ... growth. , By business unit, organic sales growth was ... Commercial. , Reported diluted EPS was $1.11 compared to ... EPS in Q2 2014 was also $1.11 compared to $1.05 ...
Breaking Medicine Technology:Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4Quest Diagnostics Reports Second Quarter 2014 Financial Results 2Quest Diagnostics Reports Second Quarter 2014 Financial Results 3Quest Diagnostics Reports Second Quarter 2014 Financial Results 4Quest Diagnostics Reports Second Quarter 2014 Financial Results 5Quest Diagnostics Reports Second Quarter 2014 Financial Results 6Quest Diagnostics Reports Second Quarter 2014 Financial Results 7Quest Diagnostics Reports Second Quarter 2014 Financial Results 8Quest Diagnostics Reports Second Quarter 2014 Financial Results 9Quest Diagnostics Reports Second Quarter 2014 Financial Results 10Quest Diagnostics Reports Second Quarter 2014 Financial Results 11Quest Diagnostics Reports Second Quarter 2014 Financial Results 12Quest Diagnostics Reports Second Quarter 2014 Financial Results 13Quest Diagnostics Reports Second Quarter 2014 Financial Results 14Quest Diagnostics Reports Second Quarter 2014 Financial Results 15Quest Diagnostics Reports Second Quarter 2014 Financial Results 16Quest Diagnostics Reports Second Quarter 2014 Financial Results 17Quest Diagnostics Reports Second Quarter 2014 Financial Results 18Quest Diagnostics Reports Second Quarter 2014 Financial Results 19Quest Diagnostics Reports Second Quarter 2014 Financial Results 20Quest Diagnostics Reports Second Quarter 2014 Financial Results 21Quest Diagnostics Reports Second Quarter 2014 Financial Results 22Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 2Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 3Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 4Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 5Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 6Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 7Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 8Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 9Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 10Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 11Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40. 12
... 1 NeurogesX, Inc. (Nasdaq: NGSX ), a ... management therapies, announced today that Anthony DiTonno, President and ... Fourth Annual JMP Securities Healthcare Focus Conference, to be ... City. , Mr. DiTonno and Stephen Ghiglieri, Chief Financial ...
... Prix Galien USA committee celebrated members of the science ... discovery of drugs and technologies that improve the human ... with the 2009 Prix Galien USA, considered the industry,s ... that could change the course of health care worldwide. ...
Cached Medicine Technology:NeurogesX to Present at JMP Securities Healthcare Focus Conference 2NeurogesX to Present at JMP Securities Healthcare Focus Conference 3Prix Galien USA Honors Innovation in Science and Biotech Industries 2
... GORE SEAMGUARD® Staple Line Reinforcement ... in reducing postoperative pulmonary air leaks ... hospital care. This inert, biocompatible, ePTFE ... non-biological.,It is easy to load and ...
... for the repair of abdominal hernias. It ... two distinct sides. One side of ... of sodium hyaluronate and carboxymethylcellulose (similar to ... side is bioresorbable, providing a temporary physical ...
... Company, we recognize that there are circumstances ... in-growth between the prosthesis and the repair ... all the products in Bards complete line ... proven, versatile repair.,The Reconix Patch is Bards ...
... PLUS Biomaterial is the first hernia ... controlling potential operative contamination of the ... two antimicrobial preservative agents, silver carbonate ... inhibit bacterial colonization on the patch ...
Medicine Products: